Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd banner

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 25.55 CNY 0.59% Market Closed
Market Cap: ¥41.1B

Operating Margin

4.6%
Current
Declining
by 1%
vs 3-y average of 5.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.6%
=
Operating Income
¥3.5B
/
Revenue
¥77.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.6%
=
Operating Income
¥3.5B
/
Revenue
¥77.5B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
41.5B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
964.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
572.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
284.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
CH
Novartis AG
SIX:NOVN
228.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.7B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120.9B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
51st
Based on 8 544 companies
51st percentile
4.6%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
41.1B CNY
Industry
Pharmaceuticals

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. stands as a prominent player in China's healthcare industry, weaving a rich legacy that dates back to its formation in the 20th century. Rooted in the dynamic city of Guangzhou, Baiyunshan reflects a harmonious blend of traditional Chinese medicine (TCM) and modern pharmaceutical innovation. The company's name itself, Baiyunshan—meaning "White Cloud Mountain" in Chinese—symbolizes its foundational connection to the city's cultural heritage and its aspiration to elevate healthcare standards. Baiyunshan's operations are a testament to its multifaceted approach to pharmaceutical production. It delves into the research and development, manufacturing, and distribution of both TCM and Western medicine. This dual approach enables Baiyunshan to cater to a diverse demographic, forging a unique path by merging ancient medical wisdom with cutting-edge scientific advancements. The core of Baiyunshan's business strategy pivots around its expansive product portfolio, which is instrumental in its revenue generation. Pharmaceuticals are at its heart, encompassing a wide range of products from patent medicines to essential drugs that are household names in China. Additionally, the company has successfully branched into the production of over-the-counter (OTC) products, health supplements, and even skincare products, broadening its consumer reach. Meanwhile, Baiyunshan's distribution network—extensive and strategically aligned—stretches across domestic and international markets, ensuring its products are widely accessible. By leveraging strategic partnerships and ongoing innovation, the company continually fortifies its market presence, making Baiyunshan a notable financial performer and a beacon of trust in the healthcare industry.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.6%
=
Operating Income
¥3.5B
/
Revenue
¥77.5B
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's current Operating Margin?

The current Operating Margin for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 4.6%, which is below its 3-year median of 5.5%.

How has Operating Margin changed over time?

Over the last 3 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd’s Operating Margin has decreased from 6.4% to 4.6%. During this period, it reached a low of 4.2% on Mar 31, 2025 and a high of 6.5% on Dec 31, 2022.

Back to Top